SynthesisEndocrine2026

Glycemic control and weight loss benefits of fixed-ratio combinations of basal insulins and GLP1 receptor agonists in type 2 diabetes: A systematic review and network meta-analysis.

A B M Kamrul-Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.